Options Traders Target Bigger Healthcare Gains

AGN is trading higher with its sector peers today

Aug 20, 2018 at 1:36 PM
facebook twitter linkedin


Healthcare stocks are trading higher today, extending an impressive run up the charts in recent months. At last check, the Health Care Select Sector SPDR ETF (XLV) is up 0.4% at $91.46 -- a chip-shot away from its Jan. 29 record high of $91.79. Options traders are responding in kind, with calls crossing the tape at four times what's typically seen at this point in the day.

By the numbers, 14,400 XLV calls have been exchanged so far, with almost 71% of this volume centered at the September 93 strike. It looks like one trader in particular bought to open 9,159 contracts at 58 cents apiece, creating an initial cash outlay of $531,222 (number of contracts * premium paid * 100 shares per contract).

This is also the most the call buyer stands to lose if XLV settles below $93 at the close on Friday, Sept. 21, when the front-month options expire. Profit, meanwhile, will accumulate on a move north of breakeven at $93.58 (strike plus premium paid) -- roughly 2.4% above the fund's current perch.

Additional upside would just mirror the exchange-traded fund's longer-term trajectory, with XLV up 16% since dipping below the round $80 in early April. Plus, in early July, the shares took out recent resistance in the $86 region, and are now trading above support at their rising 10-day moving average.

xlv daily price chart on aug 20

One XLV component getting in on today's healthcare rally is Allergan plc (NYSE:AGN), with the shares up 2.8% to trade at $190.83. The stock has added almost 33% since its mid-May lows near $143, but is running out of steam in the $190 neighborhood, which contained AGN's late-January surge.

Nevertheless, Allergan call options are crossing at three times the expected intraday pace this afternoon. Speculative players appear to be buying to open the weekly 8/24 195-strike call, betting on a break out above $195 by expiration at this Friday's close.

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Master Portfolio Trial
 


 


 
Special Offers from Schaeffer's Trading Partners